EUVIMEDEUVIMED entdecken
Crossref

Anatomical refinement matters: ureteropelvic junction location confers survival benefit for patients with upper tract urothelial carcinoma after radical nephroureterectomy

Bao Guan, Kun Peng, Chao Cao, Yicong Du, Wei Zuo, Wencong Han, Chunru Xu, Liqun Zhou, Xuesong Li, Han Hao

World Journal of Urology · 2026

DOI: 10.1007/s00345-026-06219-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Urology, 2026. Verfasst von Bao Guan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Peking University First Hospital, No. 8 Xishiku StreetXicheng District, Beijing, 100034, China. Hauptthemen laut MEDLINE: Nephroureterectomy, Ureteral Neoplasms, Kidney Pelvis, Carcinoma, Transitional Cell. Die Arbeit nennt 14 Literaturangaben. Gefördert von: Research Seed Fund Project of Peking University First Hospital, The Open Operation Project of the Key Laboratory of Urology in Guangdong Province: Open Research Topics, National High Level Hospital Clinical Research Funding (Interdepartmental Research Project of Peking University First Hospital).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Whether primary tumor location influences prognosis in upper tract urothelial carcinoma (UTUC) remains contentious. We aim to clarify the prognostic impact of tumor location in upper tract urothelial carcinoma (UTUC) by anatomically subsegmenting ureteral tumors, with specific focus on ureteropelvic junction (UPJ) carcinomas. METHODS: This retrospective cohort study evaluated 2,315 patients with non-metastatic, unifocal UTUC, including tumors localized to the renal pelvis or ureter, who underwent radical nephroureterectomy. Ureteral tumors were rigorously subsegmented into UPJ, proximal/middle/distal ureter, and ureterovesical junction (UVJ) using imaging and clinicopathological data. Survival outcomes-overall survival (OS), cancer-specific survival (CSS), metastasis-free survival (MFS), bladder recurrence-free survival (BRFS), and local recurrence-free survival (LRFS)-were evaluated using Kaplan-Meier analysis and Cox proportional hazards models adjusted for clinicopathological confounders. RESULTS: While univariate analysis showed that compared with renal pelvis tumors, ureteral tumors were associated with worse CSS, OS, MFS, BRFS and LRFS, this association was not independent in multivariable analysis. After conducting a detailed classification of the location of ureteral tumors, we discovered UPJ tumors demonstrated significantly superior OS and CSS compared to other ureteral carcinomas. Critically, UPJ location emerged as an independent predictor of improved OS (HR 0.444; 95% CI 0.240-0.820); p = 0.009) and CSS (HR 0.319; 95% CI 0.130-0.785; p = 0.013) in ureteral carcinoma patients, with the survival advantage most pronounced in muscle-invasive disease. CONCLUSIONS: Traditional "renal pelvis versus ureter" dichotomy obscures prognostic heterogeneity. Anatomical refinement that recognizes UPJ tumors as a distinct, favorable subset provides a biologically grounded framework for individualized counseling. Furthermore, the recognition of UPJ tumors as a low-risk entity may encourage the investigation of kidney-sparing management strategies in appropriately selected patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NephroureterectomyUreteral NeoplasmsKidney PelvisCarcinoma, Transitional CellKidney NeoplasmsUreterHumansRetrospective StudiesFemaleMaleAgedPrognosisSurvival RateMiddle Aged

Stichwörter der Autor:innen

Anatomical refinementClinical outcomesPrognosisUpper-tract urothelial carcinomaUreteropelvic junction

Autor:innen und Institutionen

  • Department of Urology, Peking University First Hospital, No. 8 Xishiku StreetXicheng District, Beijing, 100034, China.
  • Institute of Urology, Peking University, Beijing, China.
  • National Urological Cancer Center, Beijing, China.
  • Department of Urology, The Third Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Shangjie Town, Minhou County, Fuzhou, Fujian, China.
  • Department of Urology, Peking University First Hospital, No. 8 Xishiku StreetXicheng District, Beijing, 100034, China. pineneedle@sina.com.
  • Institute of Urology, Peking University, Beijing, China. pineneedle@sina.com.

Förderung

  • Research Seed Fund Project of Peking University First Hospital
  • The Open Operation Project of the Key Laboratory of Urology in Guangdong Province: Open Research Topics
  • National High Level Hospital Clinical Research Funding (Interdepartmental Research Project of Peking University First Hospital)

Zitieren

APA

Guan, B., Peng, K., Cao, C., Du, Y., Zuo, W., Han, W., Xu, C., Zhou, L., Li, X., & Hao, H. (2026). Anatomical refinement matters: ureteropelvic junction location confers survival benefit for patients with upper tract urothelial carcinoma after radical nephroureterectomy. World Journal of Urology. https://doi.org/10.1007/s00345-026-06219-1

Vancouver

Guan B, Peng K, Cao C, Du Y, Zuo W, Han W, et al. Anatomical refinement matters: ureteropelvic junction location confers survival benefit for patients with upper tract urothelial carcinoma after radical nephroureterectomy. World Journal of Urology. 2026. doi:10.1007/s00345-026-06219-1

BibTeX
@article{Guan2026,
  author = {Guan, Bao and Peng, Kun and Cao, Chao and Du, Yicong and Zuo, Wei and Han, Wencong and Xu, Chunru and Zhou, Liqun and Li, Xuesong and Hao, Han},
  title = {Anatomical refinement matters: ureteropelvic junction location confers survival benefit for patients with upper tract urothelial carcinoma after radical nephroureterectomy},
  journal = {World Journal of Urology},
  year = {2026},
  doi = {10.1007/s00345-026-06219-1}
}
Kostenlos starten →